BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 19435461)

  • 21. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
    Sciarretta KL; Boire A; Gordon DJ; Meredith SC
    Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of amyloid beta peptide-binding proteins: pseudo-Abeta beta-sheet surface presented in green fluorescent protein binds tightly and preferentially to structured Abeta.
    Takahashi T; Ohta K; Mihara H
    Proteins; 2010 Feb; 78(2):336-47. PubMed ID: 19731370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.
    Maji SK; Amsden JJ; Rothschild KJ; Condron MM; Teplow DB
    Biochemistry; 2005 Oct; 44(40):13365-76. PubMed ID: 16201761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrete conformational changes as regulators of the hydrolytic properties of beta-amyloid (1-40).
    Brzyska M; Trzesniewska K; Gers T; Elbaum D
    FEBS J; 2006 Dec; 273(24):5598-611. PubMed ID: 17212777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence-based modeling of Abeta42 soluble oligomers.
    Dulin F; Callebaut I; Colloc'h N; Mornon JP
    Biopolymers; 2007 Apr 5-15; 85(5-6):422-37. PubMed ID: 17211889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.
    White JA; Manelli AM; Holmberg KH; Van Eldik LJ; Ladu MJ
    Neurobiol Dis; 2005 Apr; 18(3):459-65. PubMed ID: 15755672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling amyloid growth in multiple dimensions.
    Dong J; Lu K; Lakdawala A; Mehta AK; Lynn DG
    Amyloid; 2006 Dec; 13(4):206-15. PubMed ID: 17107881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
    Shivaprasad S; Wetzel R
    Biochemistry; 2004 Dec; 43(49):15310-7. PubMed ID: 15581343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.
    Huang TH; Yang DS; Plaskos NP; Go S; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2000 Mar; 297(1):73-87. PubMed ID: 10704308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
    Milojevic J; Esposito V; Das R; Melacini G
    J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and development of non-fibrillar amyloid beta as a potential Alzheimer vaccine.
    Subramanian S; Bandopadhyay D; Mishra PK; Mathew M; John M
    Biochem Biophys Res Commun; 2010 Apr; 394(2):393-7. PubMed ID: 20214884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High resolution scanning tunnelling microscopy of the beta-amyloid protein (Abeta1-40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly.
    Losic D; Martin LL; Mechler A; Aguilar MI; Small DH
    J Struct Biol; 2006 Jul; 155(1):104-10. PubMed ID: 16650774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid beta-peptide oligomerization in silico: dimer and trimer.
    Jang S; Shin S
    J Phys Chem B; 2006 Feb; 110(5):1955-8. PubMed ID: 16471767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.
    Klein WL; Stine WB; Teplow DB
    Neurobiol Aging; 2004; 25(5):569-80. PubMed ID: 15172732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregation of Alzheimer amyloid beta peptide (1-42) on the multivalent sulfonated sugar interface.
    Fukuda T; Matsumoto E; Onogi S; Miura Y
    Bioconjug Chem; 2010 Jun; 21(6):1079-86. PubMed ID: 20486703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils.
    Okada T; Ikeda K; Wakabayashi M; Ogawa M; Matsuzaki K
    J Mol Biol; 2008 Oct; 382(4):1066-74. PubMed ID: 18692507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.